FDA.reportPublic FDA data

Pemazyre 9 MG Oral Tablet

RxCUI
2359348
RxNorm name
Pemazyre 9 MG Oral Tablet
Display name
Pemazyre 9 MG Oral Tablet
Full name
Pemazyre 9 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4Pemazyre 9 MG Oral TabletSY15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4Pemazyre 9 MG Oral TabletPSN15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4pemigatinib 9 MG Oral Tablet [Pemazyre]SBD15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614